OUR SPEAKERS 邀請講者

2024_TSIR_陳三奇

Division of Medical Oncology, Department of Oncology, Taipei Veterans General Hospital

San-Chi Chen

2017~Attending physician, Division of Medical Oncology, Department of Oncology, Taipei Veterans General Hospital 2014~2017 Attending physician, Division of Hematology and Oncology, Department of Internal Medicine, Taipei Veterans General Hospital 2011~2014 Chief resident, Division of Hematology and Oncology, Department of Internal Medicine, Taipei Veterans General Hospital 2008~2011 Resident, Department of Internal Medicine, Taipei Veterans General Hospital

  • Attending physician, Division of Medical Oncology, Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan (since 2017-08)
  • Lecturer, Institute of Clinical Medicine, School of Medicine, National Yang Ming Chiao Tung University, Hsinchu, Taiwan (since 2015-09)
  • Secretary general, Taiwan Society for Immunotherapy of Cancer (since 2021-05)
  • 1999~2006 Doctorate of Medicine, Faculty of Medicine, Taipei Medical University
  • 講者簡介 BIOGRAPHY
    • 2024 Stunning performances of oral presentation, Taiwan Joint Cancer Conference
    • 2023 Stunning performances of oral presentation, Taiwan Liver Cancer Association
    • 2023 Stunning performances of oral presentation, Taiwan Joint Cancer Conference
    • 2023 the High Distinction Award, oral presentation, Taiwan Society for Immunotherapy of Cancer annual meeting
    • 2020 the High Distinction Award, oral presentation, Taiwan Society for Immunotherapy of Cancer annual meeting
    • 2016 Young investigator high impact factor award, Taipei Veterans General Hospital
    • 2014 Stunning performances of oral presentation, Taiwan Joint Cancer Conference
    講者經歷 ACHIEVEMENTS & HONORS
  • Attending physician, Division of Medical Oncology, Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan (since 2017-08)
  • Lecturer, Institute of Clinical Medicine, School of Medicine, National Yang Ming Chiao Tung University, Hsinchu, Taiwan (since 2015-09)
  • Secretary general, Taiwan Society for Immunotherapy of Cancer (since 2021-05)
  • 1999~2006 Doctorate of Medicine, Faculty of Medicine, Taipei Medical University
  • Liu TH, Chen SC, Rau KM, Lu LC, Lin PT, Su YY, Teng W, Lai SW, Yeh RH, Kao TM, Lee PC, Wu CJ, Chen CH, Hsu CH, Lin SM, Huang YH, Chen LT, Cheng AL, Shen YC. Outcomes of post-immunotherapy durable responders of advanced hepatocellular carcinoma – with emphasis on locoregional therapy for oligoprogression. Liver Cancer 2024; https://doi.org/10.1159/000536549 . (2 nd author, IF: 13.8, Gastroenterology & hepatology, 7/93, Q1)
  • Chen SC. Challenges in translating clinical guidelines into real-life practice for management of hepatocellular carcinoma in Taiwan. Clin Mol Hepatol. 2023 Apr;29(2):352-354. (Corresponding author, IF: 8.34, Medicine, 248/7118=, Q1)
  • Lai YH, Tung KC, Chen SC. Durable response to olaparib combined low-dose cisplatin in advanced hepatocellular carcinoma with FANCA mutation: A case report. Medicine (Baltimore). 2022 Sep 30;101(39):e30719. (Corresponding author, IF:1.81, Medicine, General&Internal,122/172, Q3)
  • Doctorate of Medicine, Faculty of Medicine, Taipei Medical University